JAMES MICHAEL C 4

4 · GUIDED THERAPEUTICS INC · Filed Mar 4, 2026

Form 4

Period: 2026-02-25

Director

Transactions

Exercise of In-Money
Common Stock
[F1]
2026-02-25+100,000→ 653,495 total
Other
Warrants
[F1]
2026-02-25−100,000→ 0 total
Exercise: $0.50From: 2022-09-01Exp: 2026-09-01→ Common Stock (100,000 underlying)
Other
Warrants
[F1]
2026-02-25+100,000→ 100,000 total
Exercise: $0.50From: 2026-02-25Exp: 2027-09-01→ Common Stock (100,000 underlying)
Other
Warrants
[F1]
2026-02-25−100,000→ 0 total
Exercise: $0.65From: 2022-09-01Exp: 2026-09-01→ Common Stock (100,000 underlying)
Other
Warrants
[F1]
2026-02-25+100,000→ 152,778 total
Exercise: $0.25From: 2026-02-25Exp: 2026-02-25→ Common Stock (100,000 underlying)
Exercise of In-Money
Warrants
[F1]
2026-02-25−100,000→ 52,778 total
Exercise: $0.25From: 2026-02-25Exp: 2026-02-25→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]During February 2026, Mr. James signed an exchange agreement to exchange 100,000 warrants to purchase shares of common stock with an exercise price of $0.65 for 100,000 warrants to purchase shares of common stock for an exercise price of $0.25. The newly exchanged warrants were subsequently exercised upon payment of $25,000. Moreover, as part of the exchange agreement, the expiration date of 4-year 100,000 warrants to purchase shares of common stock with exercise price of $0.50 was extended for an additional year, until September 1, 2027.

Signature

/s/ Michael C James|2026-03-04

Documents

1 file